# KU Leuven

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/ku-leuven/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 75.4 |
| Citations | 29,347,734 |
| City | Leuven |
| Country | BE |
| Description | KU Leuven is a research organisation in Leuven, BE. OpenAlex records 310,879 works and 29,347,734 citations for it. 42,984 researchers list it as their most recent affiliation. |
| Homepage | https://www.kuleuven.be |
| OpenAlex ID | https://openalex.org/I99464096 |
| Region | Flanders |
| Researchers | 42,984 |
| ROR ID | https://ror.org/05f950310 |
| Type | education |
| Works | 310,879 |

## University papers

Showing 12 of 268.

- [Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging](https://scholariq.org/papers/recommendations-for-cardiac-chamber-quantification-by-echocardiography-in-adults/)
- [Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging](https://scholariq.org/papers/recommendations-for-cardiac-chamber-quantification-by-echocardiography-in-adults-2/)
- [Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/osimertinib-in-untreated-i-egfr-i-mutated-advanced-non-small-cell-lung-cancer/)
- [Functional profiling of the Saccharomyces cerevisiae genome](https://scholariq.org/papers/functional-profiling-of-the-saccharomyces-cerevisiae-genome/)
- [Functional Characterization of the <i>S. cerevisiae</i> Genome by Gene Deletion and Parallel Analysis](https://scholariq.org/papers/functional-characterization-of-the-i-s-cerevisiae-i-genome-by-gene-deletion-and/)
- [Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer](https://scholariq.org/papers/phase-iii-study-comparing-cisplatin-plus-gemcitabine-with-cisplatin-plus/)
- [Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/vedolizumab-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC](https://scholariq.org/papers/overall-survival-with-osimertinib-in-untreated-i-egfr-i-mutated-advanced-nsclc/)
- [Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC](https://scholariq.org/papers/overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/)
- [Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial](https://scholariq.org/papers/atezolizumab-versus-docetaxel-for-patients-with-previously-treated-non-small/)
- [Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/metastatic-non-small-cell-lung-cancer-esmo-clinical-practice-guidelines-for/)
- [An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease](https://scholariq.org/papers/an-official-european-respiratory-society-american-thoracic-society-technical/)

## University researchers

- [Coen D.A. Stehouwer](https://scholariq.org/researchers/coen-d-a-stehouwer/)
- [Alice Nieuwboer](https://scholariq.org/researchers/alice-nieuwboer/)
- [Filip Rega](https://scholariq.org/researchers/filip-rega/)
- [Michel Delforge](https://scholariq.org/researchers/michel-delforge/)
- [Filip Staes](https://scholariq.org/researchers/filip-staes/)
- [Marie‐Christine Herregods](https://scholariq.org/researchers/marie-christine-herregods/)
- [Gabriele Bislenghi](https://scholariq.org/researchers/gabriele-bislenghi/)
- [I Terrasson](https://scholariq.org/researchers/i-terrasson/)
- [Tijs Vandemeulebroucke](https://scholariq.org/researchers/tijs-vandemeulebroucke/)

## University top topics

Showing 8 of 23.

- [Semiconductor materials and devices](https://scholariq.org/topics/semiconductor-materials-and-devices/)
- [Stellar, planetary, and galactic studies](https://scholariq.org/topics/stellar-planetary-and-galactic-studies/)
- [Advancements in Semiconductor Devices and Circuit Design](https://scholariq.org/topics/advancements-in-semiconductor-devices-and-circuit-design/)
- [Astrophysics and Star Formation Studies](https://scholariq.org/topics/astrophysics-and-star-formation-studies/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Solar and Space Plasma Dynamics](https://scholariq.org/topics/solar-and-space-plasma-dynamics/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Astronomy and Astrophysical Research](https://scholariq.org/topics/astronomy-and-astrophysical-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.